thumbnail image
  • About REACTA
  • Members
  • Research & Collaboration 
    • Ongoing Projects
  • News & Events 
    • Annual Conference
    • Event Archive
  • …  
    • About REACTA
    • Members
    • Research & Collaboration 
      • Ongoing Projects
    • News & Events 
      • Annual Conference
      • Event Archive
    • About REACTA
    • Members
    • Research & Collaboration 
      • Ongoing Projects
    • News & Events 
      • Annual Conference
      • Event Archive
    • …  
      • About REACTA
      • Members
      • Research & Collaboration 
        • Ongoing Projects
      • News & Events 
        • Annual Conference
        • Event Archive
      •  Need for cooperation

        Cardiovascular Health and Lifestyle Interventions: A Randomized Controlled Trial

        Description: Investigates the impact of lifestyle interventions (e.g., exercise, dietary modifications) on cardiovascular health markers such as blood pressure, lipid profiles, and heart rate variability.
        Scale: 300 participants.
        Study Design: Randomized controlled trial with a 12-week intervention. The control group receives standard medical advice, while the experimental group undergoes lifestyle modifications.
        Objective: Identify which lifestyle changes significantly improve cardiovascular health.

        Contact

        Artificial Intelligence-Assisted Diagnostics in Diabetes Management

        Description: Evaluates the accuracy and practicality of AI-assisted diagnostic tools in blood glucose control and complication screening among diabetes patients.
        Scale: 500 diabetes patients.
        Study Design: A combination of cross-sectional analysis and 12-month follow-up.
        Objective: Validate whether AI tools enhance early diagnosis and improve patient outcomes.

        Contact

        Efficacy and Safety of Immunotherapy in Advanced Lung Cancer Patients

        Description: Assesses the therapeutic outcomes and adverse event rates of a novel immunotherapy in patients with advanced-stage lung cancer.
        Scale: 120 participants.
        Study Design: Multi-center, open-label, single-arm trial.
        Objective: Establish the efficacy and tolerability of the new immunotherapy for specific patient populations.

        Contact
      • Publication of Clinical Trials

         

        Leave your email address and we will contact you as soon as possible.

        Name *
        Email *
        Message *

      © REACTA, 2025

      Cookie Use
      We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
      Learn More